By Katherine Hamilton
Kezar Life Sciences plans to restructure and explore strategic alternatives. Shares soared 44% to $6.03 in after-hours trading Thursday.
Avita Medical shared preliminary revenue below expectations and said its CEO is stepping down. The stock shed 20% to $4.30 after the bell.
VirnetX got a long-term contract to provide cybersecurity to the U.S. Government. The stock gained 13% to $19.25.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
October 16, 2025 19:42 ET (23:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.